Eduovisual
Perioperative & Surgical Care
Anastomotic leak: recognition and management
— Colorectal (especially low pelvic/coloanal): 3–15%, highest risk
— Esophagectomy: 5–30% depending on technique
— Gastric bypass/sleeve: 1–5%
— Small bowel/ileocolic: 1–3%
— Patient: male sex (pelvic anatomy), obesity, diabetes, malnutrition (albumin <3.0), smoking, steroids/immunosuppression, prior radiation, ASA ≥3
— Operative: emergency surgery, prolonged op time, intraoperative contamination, blood loss >200 mL, low rectal anastomosis (<7 cm from anal verge), tension, poor perfusion
— Postop: vasopressor use, NSAIDs (especially diclofenac — implicated in colorectal leaks), hypoxia
— Tachycardia (often the earliest and most sensitive sign — HR >100 on POD 3–5 is a leak until proven otherwise)
— Failure to progress (ileus beyond POD 4, persistent oxygen requirement, new AKI)
— New abdominal/pelvic/chest pain, fever, or leukocytosis
Board pearl: On Step 3, unexplained postoperative tachycardia is an anastomotic leak until proven otherwise — do not anchor on "atelectasis" or "pain." Any patient who is "not doing as well as expected" after bowel surgery between POD 3–7 needs imaging, not reassurance. The mortality of a missed leak approaches 20–30%, driven by delay to source control. Early recognition (within 24 h of physiologic change) dramatically improves outcomes — a key Step 3 management principle that recurs across surgical complication vignettes.
— Subclinical/contained leak: Low-grade fever, mild leukocytosis, prolonged ileus, slow recovery. Often found incidentally on imaging or by elevated drain amylase/bilirubin. May present after discharge with vague malaise.
— Symptomatic localized leak: Focal abdominal/pelvic pain, fever 38–39°C, tachycardia, leukocytosis, purulent/feculent/bilious drain output, wound drainage, prolonged ileus, new pelvic pressure or tenesmus (low rectal).
— Free leak with peritonitis/sepsis: Diffuse peritonitis, hemodynamic instability, hypotension, lactic acidosis, AKI, altered mental status. Requires emergent operative source control.
— Esophageal: Chest/back pain, dyspnea, subcutaneous emphysema (crepitus in neck), new pleural effusion, mediastinal widening, fever, dysphagia
— Gastric (bariatric): Left shoulder pain, hiccups, tachycardia (often the only finding in sleeve leaks), inability to tolerate PO
— Colorectal: Pelvic pain, rectal bleeding, purulent rectal discharge, peritonitis, urosepsis-like picture from pelvic abscess
— Pancreaticojejunostomy (Whipple): Drain amylase >3× serum on POD 3
— Operative details: site, technique (stapled vs handsewn), diverting stoma, intraoperative leak test
— Postop course: when did the patient deviate from expected trajectory?
— Medications: NSAIDs, steroids, anticoagulants, vasopressors
— Nutrition status, comorbidities, recent chemo/radiation
Step 3 management: When a postoperative patient calls the clinic on POD 7–10 with vague abdominal pain, fever, or "just not feeling right," the correct disposition is ED referral for imaging and labs, not outpatient observation. Delayed presentation after discharge is a common Step 3 stem — patients are often dismissed as having a viral illness or constipation. The transition-of-care window (POD 5–14) is the highest-risk period for missed leak diagnosis in ambulatory follow-up.
— Tachycardia (HR >100) persistent or rising — earliest sign, often precedes other findings by 12–24 h
— Fever (typically 38–39°C, but absent in 30% — especially elderly, immunosuppressed, on steroids)
— Tachypnea (RR >20) — may reflect sepsis or diaphragmatic irritation
— Hypotension or narrowing pulse pressure — late, indicates septic shock
— Decreased urine output (<0.5 mL/kg/h)
— Tenderness beyond expected incisional pain, localized or diffuse
— Guarding, rebound, rigidity → peritonitis → emergent OR
— Distention, absent bowel sounds, prolonged ileus
— Wound: erythema, induration, purulent/feculent/bilious drainage, dehiscence
— Surgical drains: increased output, change in character (clear serous → cloudy → enteric/feculent/bilious), new bile-staining
— Neck/chest (esophageal): Subcutaneous crepitus, decreased breath sounds (effusion), Hamman's crunch (mediastinal air)
— Rectal (low colorectal): DRE may reveal defect, induration, or purulent discharge — perform gently
— Stoma: Dusky color suggests ischemia, may herald leak
— qSOFA: RR ≥22, altered mentation, SBP ≤100 → screen for sepsis
— Lactate >2 mmol/L, MAP <65, vasopressor requirement → septic shock criteria, ICU
— Capillary refill, mottling, mental status
CCS pearl: In the CCS case, when a postoperative patient shows persistent tachycardia, order CBC, BMP, lactate, blood cultures, CT abdomen/pelvis with oral and IV contrast in the same clock-tick. Do not waste simulation time on serial exams alone. Advance the clock only after orders are placed. If hemodynamically unstable, bolus IVF, broad-spectrum antibiotics, surgery consult, and OR — imaging is deferred until after stabilization or omitted entirely if peritonitis is clinically obvious.
— CBC: Leukocytosis (WBC >12, often with left shift); leukopenia in severe sepsis is ominous
— BMP: AKI, hyperkalemia, metabolic acidosis (low bicarb, anion gap)
— Lactate: >2 suggests hypoperfusion/sepsis; >4 is severe
— CRP: POD 3–5 CRP >150 mg/L has ~80% sensitivity for colorectal anastomotic leak; trending CRP is more useful than absolute value
— Procalcitonin: Adjunct; rising values support bacterial source
— LFTs, lipase, coags, type & screen, blood cultures × 2, urinalysis
— Drain fluid studies: amylase (esophageal/pancreatic), bilirubin (biliary/upper GI), creatinine (urinary leak), culture, Gram stain
— CT abdomen/pelvis with IV and oral (or rectal) water-soluble contrast is the test of choice for suspected GI leak
— Findings: extraluminal contrast, extraluminal gas/free air (beyond expected postop air, which can persist 7–10 days), perianastomotic fluid collection/abscess, bowel wall thickening, fat stranding
— CT chest added for esophageal/gastric leaks — mediastinal air/fluid, pleural effusion, pneumothorax
— Rectal contrast (water-soluble, e.g., Gastrografin) CT preferred for low colorectal anastomoses
Key distinction: Free air on postop imaging is normal up to 7–10 days after open abdominal surgery (less with laparoscopic). Do not over-call leak based on small residual pneumoperitoneum alone — the diagnostic findings are extraluminal contrast extravasation, new/expanding fluid collections, or feculent/enteric drain output. Conversely, a "negative" CT does not exclude leak if clinical suspicion is high; 20–30% of leaks have a falsely reassuring initial CT — repeat imaging in 24–48 h or proceed to operative exploration if the patient continues to deteriorate.
— Water-soluble contrast esophagram (Gastrografin swallow): For esophageal/gastric anastomoses; detects ~70–80% of leaks. Follow with thin barium if negative and suspicion remains (better mucosal detail).
— Contrast enema (water-soluble): For low colorectal anastomoses, especially before ileostomy reversal
— Avoid barium if perforation suspected — peritoneal barium causes severe granulomatous peritonitis
— Upper endoscopy: Direct visualization of esophageal, gastric, duodenal, and proximal jejunal anastomoses; allows therapeutic intervention (clips, stents, vacuum therapy)
— Flexible sigmoidoscopy/proctoscopy: Visualizes colorectal anastomosis; gentle insufflation only; can detect ischemia, dehiscence, defect size
— Timing: Generally safe after POD 3–5; coordinate with operating surgeon
— Amylase >3× serum on POD 3 → pancreatic leak (after Whipple)
— Drain bilirubin >3× serum → biliary leak
— Drain creatinine > serum creatinine → urinary leak
— Methylene blue or oral charcoal test: appearance in drain confirms leak
Board pearl: For a hemodynamically unstable patient with suspected leak, skip advanced imaging and go to the OR. Diagnostic delay kills. The Step 3 stem will give you a patient with peritonitis, lactate of 5, MAP of 60 — the correct answer is emergent exploratory laparotomy with source control, not "obtain CT with oral contrast." Imaging is for the stable patient in whom diagnosis is uncertain and operative versus non-operative management is being decided.
— Grade A: Radiographic/biochemical only, no clinical change. Management: observation, no intervention.
— Grade B: Active clinical management needed but no relaparotomy — antibiotics, percutaneous drainage, NPO, possible endoscopic intervention.
— Grade C: Requires relaparotomy — peritonitis, sepsis, hemodynamic instability.
— Hemodynamically unstable / diffuse peritonitis / feculent peritoneal contamination → OR for source control (washout, repair vs takedown vs diversion, drain placement)
— Stable patient with contained collection <3–5 cm → IV antibiotics ± percutaneous drainage
— Stable patient with localized collection >3–5 cm or abscess → percutaneous drainage + antibiotics
— Stable patient with esophageal/gastric leak → endoscopic stent, clip, or endoluminal vacuum therapy ± drainage
— Two large-bore IVs, crystalloid 30 mL/kg if hypotensive/lactate ≥4
— Blood cultures before antibiotics
— Broad-spectrum antibiotics within 1 hour (sepsis bundle)
— Foley for urine output monitoring
— Lactate, type & cross, coags, ABG
— NPO, NG decompression
— Vasopressors (norepinephrine first-line) if MAP <65 despite fluids
— Drain contamination, defunctionalize the anastomosis (diverting stoma), preserve viable bowel, plan delayed reconstruction
— Damage-control surgery (washout + temporary closure) preferred over heroic re-anastomosis in unstable septic patient
Step 3 management: The first three orders for any suspected anastomotic leak: NPO, IV fluids, broad-spectrum antibiotics. Then stratify by stability. Surgical consultation is mandatory and immediate — even for "minor" leaks, the operating surgeon decides timing and modality. Do not start clear liquids or advance diet on a patient with unexplained postop tachycardia or fever pending workup.
— First-line for community-onset, no recent antibiotics:
— Piperacillin-tazobactam 4.5 g IV q6–8h, OR
— Ceftriaxone 2 g IV daily + metronidazole 500 mg IV q8h, OR
— Ertapenem 1 g IV daily (not for critically ill or Pseudomonas-risk)
— Hospital-acquired/healthcare-associated/septic shock:
— Meropenem 1 g IV q8h or cefepime + metronidazole
— Add vancomycin 15–20 mg/kg IV q8–12h if MRSA risk, prior MRSA colonization, or hemodynamic instability
— Consider antifungal (fluconazole or echinocandin) for upper GI perforations, immunosuppressed, recurrent leaks, prolonged ICU stay, or yeast on Gram stain
— 4–7 days after adequate source control (STOP-IT trial) for complicated intra-abdominal infection
— Longer (10–14+ days) if source control incomplete, persistent bacteremia, or undrained collection
— PPI (pantoprazole 40 mg IV daily) for esophageal/gastric leaks to reduce acid/volume
— Octreotide 100 mcg SC TID for pancreatic, biliary, or high-output enteric fistulas — reduces secretion volume
— Antiemetics (ondansetron) for NG-related nausea
— VTE prophylaxis (enoxaparin 40 mg SC daily) — leak is not a contraindication once bleeding controlled
— Analgesia: Avoid NSAIDs (associated with anastomotic dehiscence); use acetaminophen + opioid + regional/epidural as appropriate
— Early enteral nutrition via NJ tube distal to leak, or TPN if enteral route unavailable
— Goal: 25–30 kcal/kg/day, protein 1.5–2 g/kg/day to support healing
Board pearl: NSAIDs (especially diclofenac and ketorolac) are associated with increased colorectal anastomotic leak rates and should be avoided in the first 7–10 postoperative days after bowel anastomosis. A Step 3 stem showing leak in a patient on scheduled ketorolac is testing this association — the management answer includes discontinuing the NSAID alongside antibiotics and source control.
— First choice for stable patient with contained collection ≥3–5 cm
— Image-guided pigtail catheter, output monitored daily, antibiotics continued
— Success rate ~70–80% for contained colorectal/abdominal leaks; avoids reoperation
— Drain fluid for culture, amylase, bilirubin, creatinine as indicated
— Self-expanding metal stents (SEMS): Cover esophageal and gastric leaks; bridge healing for 4–8 weeks
— Over-the-scope clips (OTSC, Ovesco): Close small defects (<2 cm) with fresh, non-fibrotic edges
— Endoluminal vacuum-assisted closure (E-VAC): Sponge placed in cavity via endoscope, NG suction; promotes granulation; very effective for esophageal and rectal leaks
— Fibrin glue / cyanoacrylate: Adjunct for small chronic fistulas
— Hemodynamic instability, diffuse peritonitis, failure of conservative management, large defects, ischemic bowel, abdominal compartment syndrome
— Colorectal: Takedown of anastomosis with end colostomy (Hartmann's); or proximal diverting loop ileostomy + drainage if anastomosis intact but leaking; washout; presacral drains
— Small bowel: Resection with re-anastomosis if healthy; exteriorization if unstable
— Esophageal: Drainage, T-tube, esophageal exclusion/diversion (cervical esophagostomy + gastric decompression) for catastrophic leaks; rare primary repair if early (<24 h) and tissue healthy
— Gastric (sleeve/bypass): Drainage, distal feeding jejunostomy, stent, sometimes conversion to bypass for sleeve leak
CCS pearl: In CCS, after stabilizing with fluids and antibiotics, call surgery consult and move patient to OR for unstable peritonitis. Order type and cross 4 units PRBCs, OR table, NPO confirmed, consents reviewed, central line, arterial line. Post-op, advance clock to ICU for ongoing resuscitation, vasopressor titration, lactate clearance, and daily reassessment of source control adequacy.
— Atypical presentation: May lack fever and leukocytosis; instead present with delirium, falls, failure to thrive, new AKI, or unexplained tachycardia as the only signs
— Lower physiologic reserve — sepsis progresses faster, mortality 2–3× higher
— Higher baseline frailty (assess with Clinical Frailty Scale) predicts mortality independent of leak severity
— Polypharmacy: review beta-blockers (may mask tachycardia), steroids (mask inflammation), anticoagulants (bleeding risk during reoperation)
— Goals-of-care discussion early — some elderly frail patients may prefer comfort-focused care over aggressive reoperation
— Dose-adjust antibiotics: pip-tazo, carbapenems, vancomycin, fluconazole
— Avoid IV contrast if eGFR <30 unless leak diagnosis cannot be made otherwise (risk vs benefit; hold metformin)
— Aminoglycosides relatively contraindicated; use cefepime or carbapenem
— Monitor potassium (acidosis + AKI + tissue breakdown)
— RRT may be needed for refractory acidosis, hyperkalemia, volume overload
— Higher leak rate due to portal hypertension, ascites, malnutrition, coagulopathy
— Ascites contamination → spontaneous bacterial peritonitis-like picture, often polymicrobial
— Coagulopathy: correct INR with vitamin K, FFP only if active bleeding/preoperative; avoid over-correction
— Avoid hepatotoxic antibiotics (e.g., high-dose acetaminophen, tigecycline cautiously)
— MELD score predicts surgical mortality — discuss prognosis frankly
— Blunted inflammatory response — fever and leukocytosis may be absent
— Broader empiric coverage including fungi; lower threshold for imaging
— Stress-dose steroids if on chronic steroids and septic
Board pearl: In an elderly postoperative patient with new delirium and tachycardia, the differential always includes anastomotic leak, MI, PE, UTI, and pneumonia — order CT abdomen/pelvis early. Anchoring on "sundowning" or "ICU delirium" delays diagnosis and increases mortality. Beta-blocked patients may have a "relative" tachycardia (HR 90 when baseline 60) — this is significant.
— Anastomotic leak rare; usually post-trauma, IBD surgery, or appendectomy with bowel resection
— Diagnostic imaging: MRI abdomen/pelvis without gadolinium preferred in stable patient; CT acceptable when needed for diagnosis (fetal risk < risk of missed maternal sepsis)
— Avoid fluoroquinolones (cartilage), tetracyclines (teeth), aminoglycosides (ototoxicity); pip-tazo, ceftriaxone, metronidazole (after first trimester) are safe
— Maternal sepsis is the leading cause of fetal loss in surgical complications — maternal resuscitation is fetal resuscitation
— OB consultation, continuous fetal monitoring if viable gestation, betamethasone if 24–34 weeks and delivery anticipated
— Less common; seen post-necrotizing enterocolitis surgery, atresia repair, IBD resection
— Higher reliance on clinical exam and inflammatory markers; ultrasound preferred to limit radiation
— Weight-based dosing for antibiotics; involve pediatric surgery early
— Nutrition critical — children have less reserve; TPN often required
— Leak rates 1–3%; gastric sleeve leaks classically at the angle of His (proximal staple line)
— Tachycardia (HR >120) may be the only sign — high index of suspicion
— CT with oral water-soluble contrast is initial test; upper GI fluoroscopy if CT negative
— Management: stent, drainage, antibiotics; rarely conversion of sleeve to bypass for chronic leak
— Long-term sequelae: chronic fistula, abscess, weight regain
— Rectal cancer patients post-neoadjuvant CRT have higher leak rates — diverting ileostomy often performed prophylactically
— Healing impaired by radiation effect on tissue perfusion
Step 3 management: In a pregnant patient with peritonitis and suspected leak, do not delay surgery for fetal concerns — definitive maternal source control with appropriate OB monitoring saves both lives. The greatest risk to the fetus is untreated maternal sepsis.
— Septic shock and multi-organ dysfunction — leading cause of leak-related mortality
— Acute kidney injury from hypoperfusion, nephrotoxic drugs, contrast
— ARDS from systemic inflammation
— DIC from severe sepsis
— Intra-abdominal hypertension/abdominal compartment syndrome — measure bladder pressure if abdomen tense; decompressive laparotomy if >20 mmHg with organ dysfunction
— Hemorrhage from eroded vessel adjacent to leak or post-reoperation
— Wound dehiscence, fascial dehiscence, evisceration — fascial breakdown often coincident with leak
— Enterocutaneous fistula: Leak that tracks to skin; managed with NPO, TPN, octreotide, skin protection; spontaneous closure if "FRIEND" absent (Foreign body, Radiation, IBD/Infection, Epithelialization, Neoplasm, Distal obstruction)
— Persistent intra-abdominal or pelvic abscess — may require multiple drainages
— Anastomotic stricture — late complication of healed leak; presents with obstructive symptoms 3–12 months later; managed with endoscopic dilation
— Chronic sinus/presacral cavity after low rectal anastomotic leak — may require endoscopic vacuum or transanal repair
— Permanent stoma: ~30–50% of patients with leak after low anterior resection never have ileostomy reversed
— Reduced cancer-specific survival after colorectal cancer leak (controversial but data suggest worse oncologic outcomes — possible mechanisms: delayed adjuvant chemo, tumor cell shedding into peritoneum)
— Poor functional outcome: Low anterior resection syndrome worsened by leak — incontinence, urgency, clustering
— Quality of life: Chronic pain, sexual dysfunction, body image, depression
— Overall leak mortality: 6–22%; up to 39% with delayed diagnosis or in elderly/frail patients
Board pearl: Leak after rectal cancer surgery is associated with worse long-term cancer-specific survival — a controversial but Step 3-testable association. Mechanisms include delay in starting adjuvant chemotherapy and direct effects of inflammation on residual tumor cells. This underscores the importance of prevention (proper technique, diverting stoma in high-risk) and rapid recognition.
— Even Grade A (subclinical) leaks require the operating surgeon's input on imaging, drains, diet advancement
— Document time of consultation, recommendations, and plan
— Septic shock: vasopressor requirement, MAP <65 despite fluids
— Lactate >4 mmol/L
— Acute respiratory failure (P/F <300, mechanical ventilation)
— AKI with oliguria or RRT requirement
— Altered mentation, GCS drop
— Post-emergency reoperation for source control
— Need for invasive monitoring (arterial line, CVP, frequent labs)
— Stable patient with leak being managed non-operatively (drain placed, antibiotics) but requiring close monitoring of vitals, drain output, response to therapy
— Interventional radiology for percutaneous drainage
— Gastroenterology for endoscopic stent, clip, vacuum therapy
— Infectious disease for refractory infection, multidrug-resistant organisms, fungemia
— Nutrition/dietitian for TPN, enteral access planning
— Wound/ostomy nurse for stoma care, fistula management, complex wound
— Palliative care for goals-of-care discussions in frail/elderly with poor prognosis
— Anesthesia/pain service for epidural management or chronic pain
— Community hospital → tertiary center if specialty expertise (esophagectomy leak, complex pelvic reconstruction, IR drainage, advanced endoscopy) unavailable
— Use EMTALA-compliant transfer process; stabilize first, document accepting physician
CCS pearl: In the CCS interface, place consult orders immediately when leak is suspected — "consult general surgery," "consult interventional radiology," "consult gastroenterology" all advance the management. Do not wait for imaging results to place consults; teams can be running in parallel. Also order ICU bed/transfer for any septic patient — moving location in CCS counts as escalation and improves the score.
— Expected up to POD 3–5 (small bowel) or POD 5–7 (colon); prolonged ileus beyond this is concerning
— Absent bowel sounds, distention, nausea, no flatus
— No fever, no tachycardia, no leukocytosis — distinguishes from leak
— Management: NG decompression, electrolyte correction, ambulation, gum chewing, alvimopan (post-bowel resection)
— May develop POD 5–10; often from contained spillage at original surgery
— CT shows collection without contrast extravasation from anastomosis
— Management: IR drainage + antibiotics; similar to contained leak
— Superficial (cellulitis, purulent drainage at incision); deep (fascial); organ-space (= leak/abscess by CDC definition)
— Superficial: open wound, packing, oral antibiotics if cellulitis
— Always rule out deeper source if systemic signs present
— Hemodynamic instability + drop in hemoglobin + bloody drain output
— May coexist with leak (eroded vessel)
— Management: resuscitation, reversal of anticoagulation, return to OR or IR embolization
— Post-antibiotic exposure (perioperative prophylaxis), POD 5–14
— Watery diarrhea, fever, leukocytosis, abdominal pain
— Diagnose by stool PCR/toxin; treat with oral vancomycin or fidaxomicin
— Severe/fulminant: IV metronidazole + PO vanc + rectal vanc; subtotal colectomy if megacolon
— Fascial dehiscence with fluid drainage, no enteric content
— Distinguished by drain fluid analysis (no enteric markers)
— Hematochezia or hematemesis from anastomotic line; endoscopic management
Key distinction: Ileus has no fever, no significant tachycardia, no leukocytosis, and no peritoneal signs. Any "ileus" with these features is anastomotic leak until proven otherwise — this is the classic Step 3 trap. Order CT, not just an NG tube and observation.
— POD 3–10 typical; risk factors: cancer, obesity, immobility, hypercoagulable state
— Tachycardia, hypoxia, pleuritic pain, ± hemoptysis, ± syncope
— Workup: CT pulmonary angiogram (if renal function permits), D-dimer often falsely elevated postop
— Management: therapeutic anticoagulation (balance against bleeding risk); IVC filter if anticoagulation contraindicated
— POD 0–4 most common, often silent or atypical (dyspnea, hypotension, confusion rather than chest pain)
— Troponin elevation; ECG changes; new wall motion abnormality on echo
— Management: standard ACS protocol modified for surgical bleeding risk; cardiology consult
— POD 2–7; fever, productive cough, hypoxia, infiltrate on CXR
— Hospital-acquired pneumonia coverage (cefepime ± vancomycin)
— Postop Foley exposure; dysuria often absent in catheterized patients; fever and leukocytosis
— Urinalysis, urine culture; remove Foley if no longer needed
— Classic POD 1–2 low-grade fever (though evidence weak); resolves with incentive spirometry, ambulation
— Should not cause sustained tachycardia or leukocytosis
— Beta-lactams, sulfa, phenytoin; eosinophilia, rash; resolves on discontinuation
— Calf pain, asymmetric swelling; duplex ultrasound; anticoagulation
— Pain out of proportion to exam, lactic acidosis, AF or cardiac source of emboli; CT angiography
— Epigastric pain, elevated lipase, characteristic CT findings
Board pearl: The "5 W's" of postoperative fever — Wind (atelectasis/pneumonia, POD 1–2), Water (UTI, POD 3–5), Walking (DVT/PE, POD 4–7), Wound (infection/leak, POD 5–7), Wonder drugs (drug fever, anytime) — remain a useful framework. POD 5–7 fever with tachycardia after bowel surgery = leak until proven otherwise.
— Confirm source control: drains in place, output trending down, character improving
— Clinical improvement: afebrile 48 h, WBC normalizing, lactate cleared, tolerating diet appropriate to anatomy, pain controlled on oral regimen
— Imaging confirms collection resolution if applicable
— Oral antibiotic completion if not already finished IV course (e.g., amoxicillin-clavulanate or ciprofloxacin + metronidazole) — usually 4–7 days total post-source-control per STOP-IT
— PPI continued if upper GI leak — typically 8–12 weeks
— Acetaminophen + low-dose opioid PRN — taper opioid quickly; avoid NSAIDs until cleared by surgeon (typically 4–6 weeks)
— VTE prophylaxis extended for 4 weeks post-discharge in major abdominal cancer surgery (per ASCO/ACCP)
— Stoma supplies, skin barrier prescriptions; visiting nurse for stoma teaching
— Nutritional supplements (oral protein supplements, multivitamin); some patients home with NJ feeds or TPN with home infusion service
— Ileostomy/colostomy reversal typically 3–6 months after leak resolution if patient is candidate; pre-reversal contrast enema and flexible sigmoidoscopy to confirm anastomotic healing
— Anastomotic stricture surveillance with endoscopy; dilation as needed
— Cancer surveillance continued per stage-appropriate guidelines (e.g., CEA, colonoscopy at 1 year, CT chest/abdomen/pelvis)
— Adjuvant chemotherapy if delayed by leak — coordinate with oncology to restart as soon as feasible; delay >8 weeks worsens oncologic outcome
— Optimize modifiable risk factors: smoking cessation, glycemic control (HbA1c <7–8%), nutrition (prealbumin, albumin), anemia correction
— Avoid NSAIDs perioperatively
— Diverting stoma considered in high-risk anastomoses (low rectal, post-radiation)
Step 3 management: At discharge, schedule surgery follow-up within 1–2 weeks, ensure clear instructions for return precautions (fever, increasing pain, drain changes, vomiting, lack of bowel function), and verify the patient understands medication reconciliation — particularly stopping perioperative beta-blockers if appropriate and avoiding NSAIDs. Transition-of-care errors after leak are a major patient safety issue.
— 1–2 weeks post-discharge: Surgery clinic — wound check, drain assessment, drain removal if output <20–30 mL/day and clear, review pathology, plan further imaging
— 4–6 weeks: Reassessment with imaging if indicated; oncology referral if cancer; reversal planning
— 3 months: Contrast enema or upper GI study before stoma reversal
— 6 months and 1 year: Surveillance for stricture, function, cancer follow-up
— Drain output: Volume and character (clear → straw → purulent or feculent indicates ongoing leak)
— Wound: Healing by primary or secondary intention; signs of recurrent infection
— Nutrition: Weight trend, prealbumin/albumin, oral intake; many patients lose 10–15% body weight after major complication
— Bowel function: Frequency, consistency, continence, urgency; document LARS (low anterior resection syndrome) symptoms
— Stoma function (if applicable): output volume (high-output >1500 mL/day requires intervention with loperamide, fiber, hydration), skin condition, appliance fit
— Lab follow-up: CBC, BMP, LFTs at 1–2 weeks; CEA if colorectal cancer
— Physical therapy: Deconditioning from prolonged hospitalization; structured program improves recovery
— Nutritional counseling: High-protein diet, small frequent meals, hydration
— Mental health: Screen for depression, PTSD — major surgical complications are traumatic; refer to counseling/psychiatry as needed
— Smoking cessation: Critical for any future surgery and overall recovery
— Activity: Gradual return; avoid heavy lifting >10 lbs for 6 weeks; sexual activity per surgeon guidance
— Driving: When off opioids and can perform emergency stop
— Return to work: Variable; typically 6–12 weeks depending on job demands and complication severity
Board pearl: Delayed adjuvant chemotherapy beyond 8 weeks post-colorectal cancer surgery is associated with worse oncologic outcomes. When a leak delays chemo, the goal is to start as soon as the patient is medically stable — coordinate aggressively with oncology. Document this in the care plan as a quality metric in value-based cancer care.
— Anastomotic leak must be specifically disclosed as a risk of any bowel anastomosis — including possible reoperation, stoma (temporary or permanent), prolonged hospitalization, and mortality
— Document the discussion, including site-specific risk percentages (e.g., "5–10% leak rate after low anterior resection") and contingency plans
— Edge case: If a diverting stoma was discussed preoperatively but not performed, document the intraoperative reasoning; if a stoma becomes necessary postoperatively due to leak, the patient must consent again when stable (or surrogate if unable)
— Open and honest communication about the leak is both ethically required and legally protective — "I'm sorry this happened" laws in most states protect expressions of empathy
— Use the institution's adverse event disclosure protocol; involve risk management early
— Avoid blame; focus on what happened, current management, expected course
— Handoff from OR → PACU → floor → ICU → discharge → primary care/surgeon all carry risk of dropped information
— Structured handoff tools (SBAR, I-PASS) reduce errors
— Post-discharge phone call within 48–72 hours identifies early signs of leak in patients sent home
— Medication reconciliation at every transition; clear written instructions; warm handoff to primary care
— Anastomotic leak is a NSQIP-reportable surgical complication; tracked for hospital quality benchmarking
— Some states require event reporting to health departments for never-events; leak is generally not a never-event but death from delayed recognition may trigger sentinel event review
— In frail elderly or terminally ill cancer patients, reoperation for leak may not align with patient values — early palliative care consultation, surrogate decision-maker involvement
— Respect advance directives, DNR/DNI orders; clarify that "DNR" does not mean "do not treat" — aggressive management for survivable complications is still appropriate unless patient declines
— Avoid unnecessary repeat imaging; coordinate with IR/GI to minimize procedures
— Value-based care: ERAS protocols, judicious antibiotic use (STOP-IT trial supports 4-day course post-source control)
Step 3 management: The 48–72 hour post-discharge phone call is a concrete safety intervention that catches early leaks in patients sent home. When a stem describes a patient calling the clinic on POD 8 with vague symptoms, the safe answer is bring the patient in or send to ED for evaluation, not phone reassurance.
— Amylase >3× serum = pancreatic leak
— Bilirubin >3× serum = biliary leak
— Creatinine > serum = urinary leak
— Sleeve leaks at angle of His
— Bypass leaks at gastrojejunostomy (most common) or jejunojejunostomy
— Tachycardia >120 may be only sign
Board pearl: "Unexplained tachycardia after bowel surgery between POD 3 and POD 7" is the classic Step 3 stem stem for anastomotic leak. Memorize this trigger phrase. The correct next step is CT abdomen/pelvis with IV and oral water-soluble contrast — not observation, not "treat ileus," not "give acetaminophen."
— "A 68-year-old man is POD 6 after low anterior resection for rectal cancer. He develops HR 115, T 38.5°C, mild diffuse abdominal pain. WBC 16. What is the next best step?"
— Answer: CT abdomen/pelvis with IV and rectal water-soluble contrast; start broad-spectrum IV antibiotics; NPO; surgery consult.
— Distractors: "Continue clear liquid diet and observe," "obtain CXR for atelectasis," "give acetaminophen for fever."
— "POD 4 after sigmoidectomy, patient has BP 80/50, HR 130, lactate 4.2, rigid abdomen."
— Answer: IV fluids, blood cultures, broad-spectrum antibiotics within 1 hour, surgery consult, emergent exploratory laparotomy. Do not delay for CT.
— "POD 10 after colectomy, calls clinic with vague abdominal pain, low-grade fever, decreased appetite."
— Answer: Direct to ED for CT and labs — do not manage by phone.
— "POD 2 after sleeve gastrectomy, HR 130, mild left shoulder pain, BP normal, mild leukocytosis."
— Answer: CT with oral water-soluble contrast; if negative and suspicion high, upper GI fluoroscopy or diagnostic laparoscopy. Tachycardia alone in bariatric patient is a leak.
— "POD 5 after Ivor-Lewis esophagectomy, fever, neck crepitus, new left pleural effusion."
— Answer: CT chest with contrast; esophagram; chest tube; antibiotics; ICU; consider endoscopic stent vs operative repair.
— "POD 3 after Whipple, drain amylase 4500, serum amylase 90, patient otherwise well."
— Answer: Pancreatic anastomotic leak; continue drain, octreotide, antibiotics, monitor; most resolve without reoperation.
— "POD 4 after low anterior resection. Patient has been receiving scheduled ketorolac for pain. Now febrile and tachycardic."
— Answer: Discontinue NSAID, workup for leak; tests the NSAID-leak association.
— "Patient with rectal cancer scheduled for low anterior resection post-neoadjuvant chemoradiation. Which intervention reduces clinical leak impact?"
— Answer: Diverting loop ileostomy.
Key distinction: Stable patient → image first. Unstable patient → OR first. Always include the NSAID, smoking, malnutrition, steroid, and HbA1c risk factors in your mental checklist when reading the stem — they often signal which diagnosis the question wants.
Anastomotic leak is a postoperative GI catastrophe most often presenting between POD 3 and 7 with unexplained tachycardia, fever, leukocytosis, and clinical failure to progress — diagnosed by CT with water-soluble contrast in stable patients, confirmed by extraluminal contrast or enteric drain output, and managed by NPO, broad-spectrum antibiotics, source control (percutaneous drainage for contained collections, endoscopic stenting/vacuum for upper GI, operative diversion and washout for peritonitis), with mortality determined by speed of recognition.
Board pearl: When in doubt on Step 3, image the unexplained postoperative tachycardia — atelectasis, dehydration, and pain are diagnoses of exclusion, not first guesses, in any patient with a fresh GI anastomosis. Early recognition is the single intervention with the greatest impact on survival.